Irish hospital software group Oneview Healthcare has secured another contract in the United States. The listed company will roll out its interactive patient care product in Lancaster General Hospital, which
General practice in Scotland will benefit from an extra £250 million a year by 2021 under wider plans to raise overall annual funding for primary care by £500 million, Scottish
Representatives from the European Medicines Agency (EMA) met with medicines regulators from Africa last week to discuss how to improve the availability of high quality, safe and effective medicines to
Cambridge Academy of Therapeutic Sciences aims to create world-leading industry-academia collaborations with new initiative The Cambridge Academy of Therapeutic Sciences (CATS), a new initiative that aims to establish a world-leading
The Museum of the History of Science in Oxford is hosting an exhibition on the history of penicillin and the current challenges of antibiotic resistance featuring the first culture used
A medical team from Clínica Universidad de Navarra in Pamplona has successfully performed Spain’s first implant of the SynCardia temporary Total Artificial Heart. The 47-year-old patient, was suffering from severe
Frost & Sullivan, Gary Jeffery comments on the implications of Brexit for businesses both in and out of the UK. Theresa May set out an ambitious plan of maintaining a
Healthcare giant Johnson & Johnson is planning to close its medical manufacturing plant in West Lothian, Scotland, potentially affecting around 400 jobs. The company said it has now triggered a
SenzaGen and AstraZeneca will develop a new genomic signature to distinguish allergens from irritants in the respiratory tract Swedish in vitro testing company, SenzaGen, has signed a collaboration agreement with
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to
Score one for Samsung Bioepis in its quest to bring a biosimilar version of AbbVie’s anti-inflammatory behemoth Humira to market in Europe. This week, a U.K. court upturned two of the
In an editorial published in the journal ecancermedicalscience, leading academics from across the UK explore the risks facing cancer care, treatment and research in a post-Brexit world. The editorial is
A survey conducted by Fortune determined that the company are most admired by peers out of all the pharma companies globally Johnson and Johnson’s work on HIV may have earned
Researchers at the Universities of Dundee and Edinburgh in Scotland are looking to work with the pharmaceutical industry to improve understanding of the biological processes that could form the basis
Dublin-headquartered pharma company Allergan is to invest €42 million in its Irish operations this year. The company, which employs approximately 1,700 people in the Republic, has also announced details of
The report, commissioned by the Association of the British Pharmaceutical Industry (ABPI) and supported by the Association of the British Healthcare Industry (ABHI), the BioIndustry Association (BIA), and the British
In September 2015, the German Volkswagen Group, the world’s largest car producer, admitted to having installed “defeat devices” in 11 million diesel cars sold worldwide between 2008 and 2015. The
In a landmark decision, the United States FDA and the European Commission announced on March 2, 2017 that they will recognize each other’s inspection assessments at pharmaceutical manufacturing facilities. The Mutual
Price rises in the EU stir Members of European Parliament to discuss ways to make medicines more affordable, including increasing clarity on R&D costs New medicine prices in the EU
Sheffield Teaching Hospitals NHS Foundation trust will lead a new virtual specialist surgical centre, designed to tackle complex rare urogenital disorders such as pelvic floor dysfunction and bladder control problems.
Oneview Healthcare, the Irish hospital software group, has reported strong revenue growth in its first year as a listed company.
On 1 March the newly established European Reference Networks (ERNs) has started their work. ERNs are unique and innovative cross-border
Total revenues at Irish-headquartered Jazz Pharmaceuticals increased 12 per cent in 2016 to $1.5 billion (€1.42 billion ), while net
Early-phase contract research organisation Richmond Pharmacology has opened its new research facility in London Bridge, at the site formerly known
Irish consumer healthcare and generic drug group Perrigo said has agreed to sell the royalty stream from its multiple sclerosis
The company’s latest report states that key drivers of the Russian healthcare market include improving regulatory guidelines and government initiatives
The Irish division of Crowthorne Hi-Tec Services (CHTS) has joined forces with Biopharma Group to offer combined services throughout the whole
Big Pharma companies Pfizer, Sanofi and Johnson & Johnson were among the big investors last year in the Flanders region of
FDA’s Office of Generic Drugs (OGD) released their 2016 Annual Report on Feb. 24, 2017. The report details the office’s accomplishments
The European Medicines Agency (EMA) announced on Feb. 24, 2017 that its Committee for Medicinal Products for Human Use (CHMP) has
Boston Scientific said on Thursday it was recalling a range of heart devices made at its Galway plant, sending the
On Feb. 23, 2017, Novasep announced the opening of its new €11-million (approximately $11.64 million) bioconjugation unit in the
Mundipharma is gearing up to launch biosimilar Truxima in seven European markets for the treatment of certain cancers and inflammatory
Dublin-domiciled Medtronic, the world’s largest standalone medical device maker, saw profits more than double at its main Irish subsidiary last
Roche’s oral ALK inhibitor, Alecensa, has been conditionally approved in the European Union as a monotherapy for anaplastic lymphoma kinase-positive
The company has entered into a three-year agreement with Valeant Pharmaceuticals Ireland for the distribution in Europe, the Middle East
Cambridge Research Biochemicals (CRB), specialist in the synthesis of custom peptides and antibody production has announced the release of its new
Faron Pharmaceuticals has recruited its first patient to a phase II clinical trial of its lead drug, Traumakine, in the
UK-based rare and speciality diseases group Mereo BioPharma says its brittle bone disease drug BPS-804 has been accepted to participate
On Feb. 2, 2017, FDA issued a warning letter to Sato Pharmaceutical Co., Ltd. after inspectors found current good manufacturing
Sartorius announced on Feb. 17, 2017 that it was partnering with the European Molecular Biology Laboratory (EMBL) research institute to advance
Over five million patients will soon be able to access Wi-Fi in early adopter GP practices as the NHS takes
Basel-based BioMedPartners announes the first round of BioMedInvest III, its third equity venture capital fund at CHF75m. Up to 16
Healthcare communications specialists Fiona Edwards and Katie Langdon have launched a new creative agency specialising in pharmaceutical marketing services. Based
Advertisements
